Stock
Ascentage Pharma Group Intl
Ticker not mapped · held by 7 managers
Reported value
$721.7K
Holders
7
+0 new · −5 exited
Holders’ est. mark
−$70.2K
Price effect on 7 books still in the name
Largest holder
$383.3K
Point72 Asset Management, L.P.
Holder count by quarter
Who holds it
Notable only| Investor | Shares | Value | Est. mark | Change |
|---|---|---|---|---|
| Point72 Asset Management, L.P. | 16.1K | $383.3K | −$38.1K | Cut−$55.6K |
| XY Capital Ltd | 13K | $310.6K | −$30.8K | Cut−$47K |
| Tower Research Capital LLC (TRC) | 518 | $12.4K | −$545 | Added$6.33K |
| MORGAN STANLEY | 498 | $11.9K | −$363 | Added$7.87K |
| UBS Group AG | 124 | $2.96K | −$294 | Cut−$108.1K |
| EverSource Wealth Advisors, LLC | 24 | $573 | −$57 | Cut−$57 |
| ROYAL BANK OF CANADA | 6 | $0 | $0 | Held |
Who left
Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.